Cellosaurus A4.6.1 (CVCL_D3F4)
| Cell line name | A4.6.1 |
|---|---|
| Synonyms | A.4.6.1 |
| Accession | CVCL_D3F4 |
| Resource Identification Initiative | To cite this cell line use: A4.6.1 (RRID:CVCL_D3F4) |
| Comments | Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized bevacizumab (Avastin) therapeutic antibody used for the treatment of a number of cancers and of age-related macular degeneration. Monoclonal antibody isotype: IgG1. Monoclonal antibody target: UniProtKB; P15692; Human VEGFA. |
| Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
| Hierarchy | Parent: CVCL_3412 (P3X63Ag8U.1) |
| Category | Hybridoma |
| Publications | PubMed=1380254; DOI=10.3109/08977199209023937 |
| Cross-references | |
| Biological sample resources | ABCD; ABCD_AE653 |
| Entry history | |
| Entry creation | 30-Jan-2024 |
| Last entry update | 30-Jan-2024 |
| Version number | 1 |